All the Alphas: Searching for Success in Active Investment Management.
The active investment management industry exists to generate above-market returns, called investment alpha. With passive index managers plundering assets from active managers, this approach isn't sustainable.
Active investment managers need to surface the value of data inside their firms. Silo'ed and scattered data hides untapped value. Delivering exceptional performance (alpha) across functions, such as distribution, service, and transformation creates enduring competitive advantage.
Read this white paper to learn how asset managers can use AI-Powered Search to:
- Rethink competitive survival and success.
- Learn how one of our customers saves over $21 million per year with All the Alphas.
- Implement All the Alphas. These include alphas for distribution, service, transformation, investment research, M&A, and new products.
- Maximize value from all your data. External and internal. Structured and unstructured.
Download the whitepaper.
Discover what Sinequa can do for your business.
Other whitepapers.
KM World: Best Practices in Cognitive Computing
This white paper offers a definition of Cognitive Computing supported by concrete use cases showing how cognitive information systems are capable of extracting insights from big and diverse data sets for users in their work context.
Cognitive Search for Mergers & Acquisitions
The success of a merger can be greatly enhanced when business processes are integrated and information is seamlessly unified. Sinequa helps organizations facilitate successful merger and acquisition initiatives.
Turning Data into Insight: Cognitive Search & Powerful Analytics for Life Science
Finding relevant knowledge in the complex and diverse data of Biopharma companies requires cognitive systems using Natural Language Processing (NLP) capable of "understanding" what unstructured data from texts and videos is about. This whitepaper highlights how Cognitive Search and Analytics are key elements for driving innovation, improving the efficiency of research, clinical trials, and regulatory processes.
